Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
other: SNIF file released by ECHA
Title:
Unnamed
Year:
1987
Report date:
1987

Materials and methods

Objective of study:
other: To examine the skin penetration of a 5% (w/w) formulation of the test substance after a single application
Test guideline
Qualifier:
according to guideline
Guideline:
other: Penetration through human epidermis in vitro
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate
EC Number:
402-070-1
EC Name:
Tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate
Cas Number:
88122-99-0
Molecular formula:
C48H66N6O6
IUPAC Name:
2-ethylhexyl 4-({4,6-bis[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl}amino)benzoate
Test material form:
solid: particulate/powder
Radiolabelling:
no

Test animals

Species:
other: Samples of human epidermis

Administration / exposure

Route of administration:
dermal
Vehicle:
other: 5% test substance in a sunscreening product formulation
Control animals:
no

Results and discussion

Metabolite characterisation studies

Metabolites identified:
not measured

Any other information on results incl. tables

Approx. 0.1% (= approx. 0.05 ug/cm^2) at the high dose (10 mg of the preparation/cm^2) and approx. 1.3% (= approx 0.065 ug/cm^2) at the low dose (1 mg of the preparation/cm^2) have penetrated the epidermis 24 hours after application.

Applicant's summary and conclusion